Developmental toxicity and mechanism of dibutyl phthalate on the development of subintestinal vessels in zebrafish Authors: Wei Peng, Xiaokun Yi, Yuyang Peng, Huiqiang Lu, Haijin Liu Published: 2024 ABSTRACT Background: The dibutyl phthalate (DBP) is a member of the phthalate family and is widely used as a plasticizer in daily life and production. However, the influence of DBP on the vascular developmental remains unclear. Methods: In this study, we used zebrafish as a model organism to investigate the effects of DBP on vascular development in vivo. Death curves of zebrafish at different concentrations of DBP exposure and different times incubation were made firstly. Zebrafish embryos after fertilization for 5.5 h were exposed to different concentrations of DBP solution (0, 0.4, 0.8, 1.2 mg/L), the body length, yolk sac absorption area, mortality and heart rate of zebrafish were measured, and the number and area of sprouting of ventral vessels were quantified by transgenic fish system. Reactive oxygen species (ROS) in zebrafish embryos were observed by DCFH-DA staining. Super oxide dimutese (SOD) and catalase (CAT) were determined with ELISA kits. Results: We found that DBP increased the oxidative stress level of zebrafish exposed to DBP, and the genes related to vascular development also increased. Meanwhile, the activities of SOD and CAT were greatly decreased after DBP exposure. In the rescue experiment, we found that the antioxidant astaxanthin and the small molecule VEGF inhibitor ZM-306,416 can reverse the vascular dysplasia caused by DBP. Conclusions: DBP induced vascular developmental toxicity by enhancing oxidative stress levels, activating HIF pathway, and interfering with the expression of vascular development-related pathways in zebrafish, results in the abnormal development of the subintestinal vessels in zebrafish.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-024-80088-9. Introduction With the development of economy, the production and application of plastics are more and more extensive. In 2016 alone, the world produced about 335 million metric tons of plastic, of which China is the major producer1. And phthalate used as plasticizers in plastics production are also widely used because of their ability to increase the toughness and endurance of plastics products. As a member of the dibutyl phthalate family, Dibutyl Phthalate (DBP) can be used as a plasticizer and has strong solubility for various resins. DBP is mainly used in the processing of polyvinyl chloride and can endow products with good flexibility. Due to its low cost and ease of processing, it has a wide range of applications. Its application range includes ceramic tile, paint, sealant, and cosmetics, shampoo, perfume, candles, creams and so on2. Because such compounds bind plastic polymers not by covalent bonds, but by weaker intermolecular force. As a result, DBP is continuously released into the environment, Atmosphere, food, and even into the human body from medical devices3. It is also banned in cosmetics and certain toys, particularly those designed to be placed in a child’s mouth, as outlined by the European Union Toy Safety Directive. The U.S. has restricted the use of DBP in children’s toys and childcare products under the Consumer Product Safety Improvement Act4. The non-degradability of DBP allows it to be enriched in human tissues. It has been reported that DBP can be detected in human urine, blood, sweat glands, hair follicles and other subcutaneous tissues3,5. It is mainly accumulated in fatty organs such as the liver, kidneys and even testicles in the human body. Studies have shown that a variety of diseases are associated with DBP exposure, such as coronary heart disease, obesity, ovarian dysfunction, childhood autism, and inflammation6,7. Its wide range of harm, the human body, many organs, many systems are toxic or potential toxicity. DBP is considered an endocrine disruptor. Studies have shown that exposure to DBP can result in decreased sperm quality and testosterone production, and in severe cases, it may lead to testicular damage and developmental disorders. Animal studies have shown that prenatal exposure to DBP can cause malformations in the reproductive system and abnormalities in the brain8. Chronic exposure of DBP may lead to liver inflammation and fatty liver changes, resulting in impaired detoxification processes in the body9. However, there are no studies that show the specific effects or harms of DBP on Vascular Development. In view of the extensive application of DBP and its bioaccumulation, it is of great public health significance to explore its potential impact on vascular development. Zebrafish is a model organism widely used in biological research. Compared with traditional model animals, zebrafish embryos are characterized by small size, optical translucency and genetic processability, coupled with a large number of fluorescent transgenic lines, vascular formation in vivo can be visualized directly, greatly improving the understanding of vascular biology10. Zebrafish and human genomes share approximately 70% homology, and zebrafish genes are functionally similar to most human disease-causing genes, therefore, zebrafish are widely used in toxicological and vascular developmental studies11,12. In this study, zebrafish were used to study the effect of DBP on the development of zebrafish blood vessels and its mechanism. These findings may provide a new theoretical basis for a more comprehensive understanding of the effects of DBP on vascular development and for the treatment of vascular development disorders caused by DBP. Materials and methods Chemical reagent DBP (#84-74-2, > 99.5%) was purchased from Shanghai mclean Biochemical Technology Co., Ltd. Superoxide dismutase (SOD, #A001-3-2) and Catalase (CAT, A007-1-1) detection kits for Catalase Superoxide dismutase were purchased from Beyotime, Shanghai, China. RNA extraction kit (MagicPure® Simple Viral DNA/RNA Kit, #EC521-11), CDNA reverse transcriptase kit (TransScript® IV One-Step gDNA Removal and cDNA Synthesis SuperMix, #AW311-02) and SYBR Green (TransStart® Tip Green qPCR SuperMix, # AQ141-01) were purchased from Beijing Transgen Biotechnology Co., Ltd. The active oxygen test kit and all other reagents are purchased by Sangen Biotechnology (Shanghai, China) Co., Ltd. All other reagents are analytical grade. PBS, PTU, Tween-20 (#P9416, Sigma-Aldrich), BCIP (5-Bromo-4-chloro-3-indolyl phosphate)/NBT (nitrogen blue tetrazole) (#B5655, Sigma-Aldrich), PNST (Fast Red TR/Naphthol AS-MX Phosphate, #F4523, Sigma-Aldrich) were purchased from Sigma-Aldrich. Zebrafish strains and culture Tg(flk1:GFP) (ZFIN ID: ZDB-TGCONSTRUC-040421-1) and wild-type (WT) AB were both purchased from the Chinese zebrafish resource center and cultured at 28 ± 0.5 ℃ in a ventilated recirculating tank with light/dark cycling according to the ratio of 14 H: 10 H. Feed the newly hatched trophozoites twice daily. The study was approved by the Gannan Normal School Animal Welfare Ethics Committee, Ethics Code (GNNU2022-0628). All methods were performed in accordance with ARRIVE guidelines and the relevant guidelines and regulations. DBP exposure DBP was first dissolved in DMSO and configured into 1 mg/mL stock solution, which was stored in 4 ℃ dark environment. The well-developed fertilized embryos were randomly assigned to a six-well plate according to the density of 20 embryos per well. To avoid individual differences between zebrafish embryos or environmental factors, 40 embryos were used in each group. Equal volumes of egg water and different concentrations of DBP (0, 0.4, 0.8, 1.2 mg/L) were added to each well. The median lethal concentration (LC50) was calculated by calculating mortality at different times after exposure to different concentrations of DBP (Fig. 1A). 0.01% DMSO was used as a control. The heartbeat of viable embryos was observed under the microscope at 72 h post-fertilization (hpf), and the number of heartbeat every 60 s was counted. Fig. 1Abnormal development of zebrafish embryos induced by DBP exposure. (A) Death curves of zebrafish at different concentrations and at different times after DBP exposure. (B) Zebrafish exposed control group and 0.4,0.8,1.2 mg DBP groups were observed in whole body and local bright field. (C) The average length of zebrafish DBP at 72 hpf. (D) The average yolk area of zebrafish DBP at 72 hpf. (E) Average heart rate of zebrafish treated with DBP at 72 hpf. The blue line represents the body length and the red dotted line represents the yolk area. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. Abnormal development of zebrafish embryos induced by DBP exposure. (A) Death curves of zebrafish at different concentrations and at different times after DBP exposure. (B) Zebrafish exposed control group and 0.4,0.8,1.2 mg DBP groups were observed in whole body and local bright field. (C) The average length of zebrafish DBP at 72 hpf. (D) The average yolk area of zebrafish DBP at 72 hpf. (E) Average heart rate of zebrafish treated with DBP at 72 hpf. The blue line represents the body length and the red dotted line represents the yolk area. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. For the observation of zebrafish body with bright field, juvenile fish embryos were exposed to DBP with different concentrations of DBP (0, 0.4, 0.8, 1.2 mg/L). The control group was given 0.01% DMSO. To inhibit the production of melanin in zebrafish embryos for maintaining zebrafish transparency, and facilitating morphological observation and signal detection13, 1-phenyl-2-thiourea (PTU) was used. The PTU solution was changed every 24 h. Leica microscope was used to obtain the image under white light. To reduce errors, all microscope settings were maintained throughout the experiment. All procedures are in accordance with the China Food and Drug Administration laboratory animal care and use guidelines. Calculation of sub-intestinal germination rate Tg(flk1:GFP) embryos at 5 h hpf were treated with DBP (0, 0.4, 0.8, 1.2 mg/L) in the same way as above. The concentrations selection of DBP were mainly based on previous toxicity studies14,15. After 72 h of exposure, the larvae were anesthetized with tricaine, and the fish were placed at an angle of 30 with low melting point agar, so that the young fish could display their intestinal vessels in the largest field of vision, and the germination rate of each fish’s intestinal vessels was calculated manually. Alkaline phosphatase staining 72 hpf, 20 larvae of control group and 20 larvae of each DBP exposure group were collected. 4% Paraformaldehyde (PFA) was used for fixation at 4 ℃. It is then dehydrated in 25%, 50%, 75% and 100% methanol. Then rehydrate in 75% methanol − 25% PBT (PBS + 0.1% Tween-20) solution, 50% methanol − 50% PBT solution, 25% methanol − 75% PBT solution and rinse with 100% PBT solution. NTMT (Nitro blue tetrazolium and 5-Bromo-4-chloro-3-indolyl phosphate in Tris buffer) solution was prepared by mixing 10 mL Tris-HCl (pH 9.5, 1 M), 2 mL NaCl (5 M), 5 mL MgCl2 (1 M), and 100 µL Tween 20. Add distilled water to bring the final volume to 100 mL. Mix BCIP and NBT to the final concentration of 150 µg/mL and 300 µg/mL, respectively using NTMT. The young fish were placed in NTMT solution containing NBT and BCIP for 40 min at 37 ℃. Then Wash with 1xPNST. The whole experiment was dark. It was then stored in glycerine and photographed using a Leica Stereo microscope. Oxidative stress test To verify the level of oxidative stress in zebrafish after exposure to DBP 72 hpf, the DCFH-DA fluorescent probe (#35845, Sigma-Aldrich) was used to stain for 30 min at 1:1000 at 28 ℃ in a dark environment, followed by repeated washing with egg water until the residual probe was removed. Images of reactive oxygen species accumulation were captured using Zeiss Fluorescence microscope. The average fluorescence intensity of body parts was analyzed using ImageJ software to determine reactive oxygen species (ROS) levels in each experimental group. Zebrafish after DBP exposure at 72 hpf was collected. The tissues were washed with saline, and homogenized with PBS at a ratio of 100 µl of PBS per 10 mg of tissue at 4 °C. The homogenized tissues were centrifugated at 12,000 g for 5 min at 4 °C and the supernatants were collected. The protein concentration was measured with BCA kit (#P0009, Beyotime). OD values were determined using SpectraMax ID3 multimode microplate reader according to the instructions of Coomassie Brilliant Blue Kit. Zebrafish SOD and CAT were determined according to the commercial kits. The final results came from at least three independent experiments. RNA extraction and real-time quantitative PCR Total RNA was extracted using the TransZol Up Plus kit (#ER501-01, TranGen, Beijing, China) at various concentrations of 72 hpf after DBP exposure according to the manufacturer’s method, with 40 young fish per group. The extracted RNA quality was evaluated by photometer densitometry (OD260 and OD280 ratio) with NanoDrop OneC (Thermo Fisher Scientific, Waltham, US). 1 µg of total RNA from each group was reverse transcribed into cDNA using TransScript®II One- step RT-PCR SuperMix. Real-time fluorescent quantitative PCR was performed using SYBR green (#E096, Novoprotein, Suzhou, China) to quantify gene expression on an ABI Step 1plus RT-PCR system (Applied Biosystems, Thermo Fisher Scientific, Waltham, US), with β-actin as an internal reference gene for gene expression analysis. The primers of all genes are shown in supplementary Table 1. Each experiment is repeated at least three times independently to ensure authenticity. Each experiment was repeated at least three times independently to ensure authenticity. Rescue experiment The well-developed zebrafish embryos with 5.5 hpf were randomly assigned to six-well plates at a density of 20 in each group. 1.2 mg/L was selected as the exposure group, while the rescue group was given astaxanthin with a concentration of (80 nM) and ZM-306,416 with a concentration of (20 nM) on the premise of adding 1.2 mg/L DBP. At 72 hpf, Zeiss fluorescence microscope was used to capture the images of its intestinal vessels. Finally, the area and germination number of blood vessels in zebra fish intestine were counted by ImageJ software. Statistics All experimental data were presented as mean ± SD of at least three independent experiments and analyzed with Graphpad 8.0 software (GraphPad Software, San Diego, CA, US). One-way ANOVA was used to compare the control group and treatment group. P value < 0.05 that the difference was statistically significant. Results DBP exposure could induce embryonic developmental toxicity in zebrafish To clarify the developmental toxicity of DBP to zebrafish, the well-developed zebrafish embryos at 5.5 hpf were exposed to different concentrations of DBP (Fig. 1A). The data showed that the mortality of zebrafish embryos after DBP exposure increased in a concentration-dependent manner and tended to increase over time at the same concentration. The LC50 values for incubation of 48 h, 72 h, 96 h were 3.0, 2.1, and 1.2 mg/mL, respectively. Based on the LC50 values and previous reports, we set 0.4 mg/mL, 0.8 mg/mL, 1.2 mg/mL as the exposure group and zebrafish was observed after 72 hpf exposure. To avoid individual differences between zebrafish embryos or environmental factors, 40 embryos were used in each group. The results showed that with the increase of exposure concentration, zebrafish embryo development was affected to varying degrees (Fig. 1B), with shorter body length (Fig. 1C), slower yolk absorption area (Fig. 1D), and slower heart rate (Fig. 1E). These phenotypes suggest that DBP is developmentally toxic to zebrafish. DBP exposure could induce abnormal development of ventral vessels in zebrafish In order to investigate the effect of DBP exposure on the development of ventral vessels in zebrafish, we used Flk: GFP to observe the development of vessels in each group. Tg (FLK: GFP) can mark the endothelium specifically, and the fluorescence of the blood vessels can be observed clearly. Our results suggest that the development of ventral vessels is affected in the exposed group compared with the control group. What is more obvious is that the area of the ventral vessels is reduced, and the sprouting rate of the ventral vessels is increased (Fig. 2A). We carried out statistics on the area of the ventral vessels and number of sprouts in each group, and the results showed that the area of the ventral vessels decreased with increasing concentration (Fig. 2B), while the sprouting number increased with increasing concentration (Fig. 2C). We stained the subintestinal vessels by detecting alkaline phosphatase. The endogenous alkaline phosphatase activity of blood vessels is relatively high, and the use of alkaline phosphatase staining is a well-established method for the detection of embryonic Endothelium around 3DPF (Zhang et al., 2018). Significant abnormalities in the formation of ventral blood vessels in zebrafish following DBP exposure were observed (Fig. 2D), consistent with the results observed under fluorescence. The area of ventral vessels was significantly reduced, while the number of abnormal sprouting was significantly increased. These results suggest that during the development of subintestinal vessels in zebrafish, the exposure of DBP results in severe developmental toxicity of subintestinal vessels. Fig. 2DBP exposure can induce abnormal intestinal vascular development in zebra fish. (A) Representative images of subintestinal vascular development in zebrafish at 63 × and 112 × magnification for control and DBP groups at 72 hpf. (B) 72 hpf control group and DBP treatment group. (C) 72 hpf, the number of abnormal sprouting of ventral vessels in control and DBP groups was counted. (D) Alkaline phosphatase staining of wild zebrafish. The Red Arrows represent abnormal sprouting of blood vessels in the lower intestine. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. DBP exposure can induce abnormal intestinal vascular development in zebra fish. (A) Representative images of subintestinal vascular development in zebrafish at 63 × and 112 × magnification for control and DBP groups at 72 hpf. (B) 72 hpf control group and DBP treatment group. (C) 72 hpf, the number of abnormal sprouting of ventral vessels in control and DBP groups was counted. (D) Alkaline phosphatase staining of wild zebrafish. The Red Arrows represent abnormal sprouting of blood vessels in the lower intestine. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. DBP induced developmental toxicity during the developmental window of the ventral vessels To clarify the sensitivity of DBP to each window period of zebrafish subintestinal vascular development, we chose to perform DBP exposure experiments separately at different developmental time periods. The embryos at 5.5 hpf, 24 hpf and 48 hpf were exposed to DBP, and photographed after 72 h. As shown (Fig. 3A), there was an increase in abnormal budding rate and a decrease in the subintestinal area as the increase of DBP concentration. The abnormal budding rate and the area under the intestine in the same concentration group at the later exposure time point were decreased to some extent compared with earlier exposure group (Fig. 3B-D). This demonstrates that at any stage of the development of the ventral vessels, they remain sensitive to the toxicity of DBP. However, compared with the earlier exposure, the phenotype of the later exposure was reduced. This indicated that the toxicity of DBP to zebrafish subintestinal vessels was mainly in the early stage. Especially in the first 24 h of vascular development, this performance is particularly obvious. Fig. 3Development window of blood vessels in the intestine. Abnormal vascular development induced by DBP exposure. (A) Control group and DBP group were exposed at 5.5 hpf, 24 hpf and 48 hpf, respectively. (B) Abnormal number of ventral vessels at 72 hpf in control and treatment groups with 5.5 hpf starting exposure. (C) Abnormal number of ventral vessels at 72 hpf in control and treatment groups with 24 hpf starting exposure. (D) Abnormal number of ventral vessels at 72 hpf in control and treatment groups with 48 hpf starting exposure. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. Development window of blood vessels in the intestine. Abnormal vascular development induced by DBP exposure. (A) Control group and DBP group were exposed at 5.5 hpf, 24 hpf and 48 hpf, respectively. (B) Abnormal number of ventral vessels at 72 hpf in control and treatment groups with 5.5 hpf starting exposure. (C) Abnormal number of ventral vessels at 72 hpf in control and treatment groups with 24 hpf starting exposure. (D) Abnormal number of ventral vessels at 72 hpf in control and treatment groups with 48 hpf starting exposure. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. The effect of DBP on the development of intestinal blood vessels in zebra fish can not be compensated by the body itself In order to further explore whether the abnormal development of zebra fish’s intestinal blood vessels caused by DBP exposure can be reversed by body compensation, we chose to expose zebra fish to DBP environment continuously from 5.5 hpf to 72 hpf and then leave the DBP exposure environment, and take photos at 96 hpf to observe the development of its intestinal blood vessels. Results As shown in (Fig. 4A), after 24 h of evacuation from DBP exposure environment, the development of intestinal blood vessels in each concentration exposure group could not be significantly improved. As shown in (Fig. 4B-C), compared with the experimental group, the abnormal sprouting rate of intestinal blood vessels in each concentration exposure group still exists the phenomenon that the area of intestinal blood vessels decreases with the increase of concentration. This suggests that zebrafish exposed to DBP during the vascular developmental window are not able to reverse their toxic effects by compensation from withdrawal. Fig. 4The toxicity of DBP to the ventral vessels of zebra fish is irreversible. (A) 5.5 hpf exposure to 72 hpf withdrawal, and 96 hpf exposure to 96 hpf in control and DBP groups. (B) One day after the withdrawal of the control group and treatment group of vascular area of the intestinal statistics. (C) One day after withdrawal of the control group and treatment group intestinal abnormal bud statistics. The white dotted box indicates local magnification, and the red dotted line represents the area of the ventral vessels. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. The toxicity of DBP to the ventral vessels of zebra fish is irreversible. (A) 5.5 hpf exposure to 72 hpf withdrawal, and 96 hpf exposure to 96 hpf in control and DBP groups. (B) One day after the withdrawal of the control group and treatment group of vascular area of the intestinal statistics. (C) One day after withdrawal of the control group and treatment group intestinal abnormal bud statistics. The white dotted box indicates local magnification, and the red dotted line represents the area of the ventral vessels. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. DBP exposure disrupts the expression of genes associated with vascular pathways The above experiments indicated that DBP exposure could produce toxicity to the development of zebrafish subintestinal vessels. In order to explore the mechanism behind its action. qRT-PCR was used to detect the expression of genes related to vascular development in zebrafish after DBP exposure. The results showed that DBP exposure altered the expression of genes involved in angiogenesis-related signaling pathways such as the VEGF pathway, the BMP pathway, the HIF pathway, and the Notch pathway (Fig. 5). The expression of key genes related to VEGF pathway, such as vegfa, flt1, kdr, was up-regulated (Fig. 5A-C). This was consistent with the fact that the sprouting rate of blood vessels in the experimental group increased after DBP exposure. In addition, some signaling pathways that exist upstream of the VEGF pathway, such as the HIF pathway, are also upregulated in the expression of the key gene HIF-α (Fig. 5E). It has been reported that the Notch pathway can antagonize the VEGF pathway to regulate vascular budding (Fig. 5F), and the expression of dll4 on the NOTCH pathway decreased significantly with the occurrence of the exposure compared with the control group. In contrast to the above gene expression trends, gene expression of bmp16 on the BMP pathway (Fig. 5D) decreased with increasing concentrations. These results suggest that DBP exposure may cause vascular development disorder in zebrafish and lead to abnormal expression of genes related to vascular pathways. Fig. 5DBP exposure changed the expression of vascular related pathway genes. (A-C) Representing changes in expression of VEGF pathway-related genes in control and DBP groups. (D) Represents gene expression changes of BMP16 on the BMP pathway in control and treatment groups. (E) Indicates changes in gene expression of HIF1 αa on the HIF-α pathway in control and treatment groups. (F) Indicates changes in gene expression of DLL4 on the NOTCH pathway in control and treatment groups. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. DBP exposure changed the expression of vascular related pathway genes. (A-C) Representing changes in expression of VEGF pathway-related genes in control and DBP groups. (D) Represents gene expression changes of BMP16 on the BMP pathway in control and treatment groups. (E) Indicates changes in gene expression of HIF1 αa on the HIF-α pathway in control and treatment groups. (F) Indicates changes in gene expression of DLL4 on the NOTCH pathway in control and treatment groups. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. DBP exposure can induce oxidative stress in zebrafish embryos The increase of oxidative stress level can abnormally activate HIF pathway, and finally regulate the abnormal expression of downstream pathways such as VEGF through cascade reaction. In order to investigate the changes of oxidative stress in zebrafish embryos after DBP exposure, the distribution and concentration of ROS in zebrafish embryos were observed by DCFH-DA staining, the activities of SOD and CAT were determined. There was a strong accumulation of reactive oxygen species in the head, heart, and cardiovascular sites (Fig. 6A), with a significant increase in their intensity compared with the control group (Fig. 6B). The activity of SOD and CAT were decreased significantly (Fig. 6C-D). This indicated that the level of oxidative stress in zebrafish was obviously increased after DBP exposure, and the abnormal activation of oxidative stress might be the main cause of subsequent vascular development disorder. Fig. 6DBP exposure can cause oxidative stress in zebrafish embryos. (A) Representative reactive oxygen species staining of control and DBP groups. (B) Reactive oxygen species fluorescence intensity statistics. (C) Catalase activity. (D) Superoxide dismutase activity. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. DBP exposure can cause oxidative stress in zebrafish embryos. (A) Representative reactive oxygen species staining of control and DBP groups. (B) Reactive oxygen species fluorescence intensity statistics. (C) Catalase activity. (D) Superoxide dismutase activity. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. Astaxanthin and ZM-306,416 could rescue the vascular toxicity of zebrafish induced by DBP To further verify that DBP-induced vascular toxicity in zebrafish is caused by a cascade of aberrant expression of oxidative stress, we used the antioxidant astaxanthin and the VEGF inhibitor ZM-306,416, respectively, to try to rescue. After rescue with Astaxanthin and ZM-306,416, some of the subjects in the high-concentration group were relieved to some extent (Fig. 7A-F). After adding astaxanthin, the subintestinal vascular morphology of 6 zebrafish exposed to 1.2 mg/L DBP was improved, the area of lower intestinal blood vessels increased, and the abnormal germination rate of lower intestinal blood vessels decreased, which was also observed after adding ZM-306,416. The morphology of subintestinal blood vessels was improved in 8 of 15 zebrafish exposed to 1.2 mg/L DBP (Fig. 7D, F). In addition, we used qRT-PCR to re-examine the expression of vascular development genes in each group. After being rescued by Astaxanthin and ZM-306,416, the expression levels of vegfaa, flt1, kdr, hif1αa decreased (Fig. 7G-J). The results showed that Astaxanthin and ZM -306,416 could alleviate the subintestinal vascular toxicity of zebrafish induced by DBP. Fig. 7Astaxanthin and ZM-306,416 can partially rescue DBP-induced zebrafish vascular toxicity. (A-F) Does not indicate the zebrafish under each solution environment under the intestinal blood vessel development situation. (G-J) The expression levels of vascular development related genes. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. Astaxanthin and ZM-306,416 can partially rescue DBP-induced zebrafish vascular toxicity. (A-F) Does not indicate the zebrafish under each solution environment under the intestinal blood vessel development situation. (G-J) The expression levels of vascular development related genes. * indicates P < 0.05 compared with the control group, * * indicates P < 0.01 compared with the control group, and * * * indicates P < 0.001 compared with the control group. Discussion With the development of life and production, a large amount of DBP is discharged into the Environment, and its exposure route is very extensive. Because it can be enriched in organisms, DBP has higher toxicity. According to previous reports, DBP can promote angiogenesis in human endothelial cells via PI3K-AKT and NO signaling pathways16. However, it has not been reported whether DBP can regulate the development of blood vessels in vivo. Therefore, we adopted transgenic zebrafish as a model animal to further study the toxicity of DBP on blood vessels in vivo. We exposed zebrafish embryos 5.5 h after fertilization to an environment (0, 0.4, 0.8, 1.2 mg/L) up to 72 hpf after fertilization. We found an abnormal phenotype of vascular development in the location of the ventral vessels in the exposed group. Compared with the control group, the sprouting rate of the ventral vessels in the exposed group was significantly increased. In addition, we observed that the area of the ventral vessels in the exposed group was significantly smaller than that in the control group. This indicated that the development of blood vessels in zebrafish was affected after DBP exposure, and the high level of abnormal budding rate in the exposure group also proved that DBP may promote the angiogenesis of zebrafish. This is consistent with the reported results of in vitro studies. vegfa, flt1, kdr are VEGF pathway related genes, and VEGF pathway has been reported closely related with angiogenesis of zebrafish. Notch is the upstream pathway of the VEGF, and Notch pathway can antagonize the VEGF pathway to regulate vascular budding17. We found that DBP exposure could increase the levels of vegfa, flt1, kdr, but decrease dll4, indicating that DBP may have potentially serious angio-developmental toxicity to zebrafish. Previous study indicated that from 24 to 48 hpf, subtinal vessel formation starts, as endothelial cells begin to sprout and migrate to form a vascular plexus around the yoke sac. During 48–72 hpf, the subtinal vessels continue to develop and organize into a more structured network. During 72–120 hpf, the subtinal vessel matrix, forming a distinct basket like network around the yoke sac, and the vascular architecture becomes more stable18,19. In this research, we investigated if toxic effects caused by DBP could be reversed by compensation at 96 hpf. An earlier observation time point would have been more appropriate, which is a limitation of our research. The establishment of blood vessels is an important event during embryonic development. The formation of new blood vessels involves two mechanisms, one called vasculogenesis and the other called angiogenesis. In simple terms, vasculogenesis is the formation of blood vessels from scratch, whereas angiogenesis is the process by which old blood vessels germinate and generate new blood vessels20. Whether it is vasculogenesis or angiogenesis, the correct expression of multiple signalling pathways underlies these two mechanisms, such as the Wnt pathway, the Notch pathway, the BMP pathway, the HIF-α pathway, the PI3K-mTor pathway21–23, and so on, these signalling pathways directly or indirectly affect the VEGF pathway, and ultimately play a role in the regulation of vascular development. In which mobilization of inflammatory cells is associated with angiogenesis, inflammatory cells are often the main source of ROS24. Under normal physiological conditions, ROS levels are automatically regulated by the body and act as messengers in normal cell signalling, cell cycle, gene expression, and homeostasis. When oxidative stress occurs in the body, the imbalance between oxidation and anti-oxidation in the body, when excessive ROS is produced, finally induced disease. In the vascular system, this functional association between the inflammatory dependence of ROS and angiogenesis plays an important role in vascular disease25. It was reported that excessive ROS presented anti-angiogenic effects and toxicity on zebrafish. The increased ROS by DBP might be a potential inducing factors of vascular developmental toxicity of zebrafish26. The production of oxidative stress can induce cellular inflammatory responses and promote angiogenesis. In previous studies, it has been repeatedly shown that DBP is able to induce elevated levels of oxidative stress in the body, promoting the production of large amounts of ROS27,28. ROS are able to induce the activation of HIF-α, thus causing the activation of downstream pathways that regulate vascular development29. In this experiment, we analyzed the content of ROS, the activities of SOD and CAT, compared with the control group, the level of ROS was increased, but the levels of SOD and CAT were decreased in the DBP exposed group. The above experimental results confirm our conjecture, DBP may enhance the level of oxidative stress in zebrafish, induce activation of the HIF-α pathway, interfere the expression of some angiogenic genes and exert vascular developmental toxicity. In this study, we also carried out the rescue experiment of DBP-induced vasculogenic toxicity. We tried to rescue the exposed group by using the antioxidant astaxanthin and ZM-306,416. The results showed that the recovery ratio of astaxanthin at 80 nM was 6/16, while that of ZM-306,416 at 20 nM was 8/15. The recovery ratio of Astaxanthin at 80 nM was higher than that of ZM-306,416 at 20 nM. The results showed that the morphology of the ventral vessels was improved and the area of the ventral vessels was increased in the DBP-treated group, the abnormal sprouting rate of ventral vessels was reduced to some extent. And after collecting samples from the control group, the experimental group and the rescue group, and examining the expression of genes related to vascular development in each group, the results also showed that the expression levels of vegfa, flt1, kdr, hif1-aa were decreased in the rescue group, which also confirmed our conjecture. Exposure to DBP has been associated with several long-term health consequences in humans. Studies suggest that endocrine disruptors like DBP can contribute to metabolic syndrome, increasing the risk of hypertension, obesity, and diabetes, which are all linked to cardiovascular disease16. DBP exposure has been linked to male reproductive issues, such as decreased sperm quality and testosterone levels. In females, it may disrupt ovarian function and lead to infertility or irregular menstrual cycles30. Prenatal and early-life exposure to DBP can affect fetal development, potentially leading to congenital disabilities, neurodevelopmental disorders, and behavioral issues in children31. For individuals already exposed to DBP, potential therapeutic interventions should be applied. Supportive therapies aimed at enhancing detoxification processes, such as increasing hydration, nutritional support with antioxidants, and possibly the use of chelating agents, may help reduce DBP levels in the body32. Public health initiatives play a crucial role in addressing the risks of DBP exposure. It is necessary to educate the public about the sources and health risks of DBP, which can empower individuals to make informed choices regarding product usage and dietary habits. It is helpful to use safer chemical alternatives to DBP in consumer products can help reduce exposure risks. Meanwhile, future research on DBP should consider several key areas, the effects of DBP on different vascular beds, interactions with other contaminants, consequences of long-term DBP exposure. DBP exposure is closely related to daily life. Human exposure to DBP can occur in several real-world scenarios, including, vinyl flooring, adhesives, plastics, cosmetics, contaminated food. The negative effects of DBP on endocrine disruption, developmental toxicity, toxicity to organs have been demonstrated33. Currently, DBP is banned in children’s toys and childcare articles by U.S. and Canada. Here are some suggestions to mitigate risks associated with DBP. (1) alternative plasticizers that are less harmful, such as dinch or diethylhexyl phthalate, could be used; (2) The application of DBP in children and pregnant women related products should be limited or banned; (3) The products containing DBP should be informed; (4) Continuous monitoring of DBP should be carried out, and research on its impact should continue to be conducted. However, using zebrafish model to study the influence of DBP on developmental toxicity contains some limitations. Zebrafish may metabolize DBP differently than humans, leading to variations in toxicity and systemic effects. Their rapid development and unique physiological traits may not fully mimic human responses. The long-term health effects observed in humans, such as chronic diseases, may not be adequately captured in zebrafish due to their shorter lifespan and different environmental interactions. Zebrafish are typically studied in controlled laboratory conditions, which may not reflect the complexities of human exposure scenarios, including diet and lifestyle factors34,35. Meanwhile, individual differences between zebrafish embryos might also affect the results. Rodents might have some advantages compared with zebrafish. Rodents share more genetic and metabolic similarities with humans, providing insights into the mechanisms of DBP toxicity that may be more relevant to human health. Rodents can be studied over longer periods, allowing researchers to investigate chronic health effects and the progression of diseases associated with DBP exposure36. Therefore, using a combination of zebrafish and rodent models can enhance the robustness of research findings and better inform risk assessments related to DBP exposure in humans. Conclusion DBP induced vascular developmental toxicity in zebrafish, which resulted in abnormal development of subintestinal vessels in zebrafish, the vascular developmental toxicity may be induced by enhancing the level of oxidative stress in zebrafish, inducing the activation of HIF pathway and interfering the expression of downstream vascular developmental related pathways. These findings provide new evidence for a more comprehensive understanding of the vascular toxicity of DBP and provide a data complement to the relatively scarce field of research on the toxicity of DBP to the vascular system, confirming the toxic effects of DBP on Vascular Development in Zebrafish; It provides a new perspective for the toxicology study of related environmental pollutants in the future. Electronic supplementary material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1